L
Laura de Girolamo
Researcher at University of Milan
Publications - 146
Citations - 3043
Laura de Girolamo is an academic researcher from University of Milan. The author has contributed to research in topics: Mesenchymal stem cell & Medicine. The author has an hindex of 27, co-authored 116 publications receiving 2173 citations.
Papers
More filters
Journal ArticleDOI
Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy
Laura de Girolamo,Enrico Lucarelli,Giulio Alessandri,Maria Antonietta Avanzini,Maria Ester Bernardo,Ettore Biagi,Anna T. Brini,Giovanna D'Amico,Franca Fagioli,Ivana Ferrero,Franco Locatelli,Rita Maccario,Mario Marazzi,Ornella Parolini,Augusto Pessina,Maria Luisa Torre +15 more
TL;DR: Recent developments regarding MSCs properties, physiological effects, delivery, clinical applications and possible side effects are described.
Journal ArticleDOI
Human adipose-derived stem cells isolated from young and elderly women: their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation.
Laura de Girolamo,Silvia Lopa,Elena Arrigoni,M.F. Sartori,Franz Wilhelm Baruffaldi Preis,Anna T. Brini +5 more
TL;DR: It is shown that age does not seem to affect cell viability and in vitro adipocytic differentiation significantly, whereas it does affects osteoblastic differentiation, in the absence and presence of two-dimensional and three-dimensional scaffolds.
Journal ArticleDOI
Isolation, characterization and osteogenic differentiation of adipose-derived stem cells: from small to large animal models
TL;DR: Analysis and characterized adipose-derived stem cells isolated from adipose tissue of rat, rabbit and pig and compared their in vitro osteogenic differentiation abilities for exploitation in the repair of critical osteochondral defects in autologous pre-clinical models.
Journal ArticleDOI
Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences.
TL;DR: Despite the constant presence of positive and satisfactory results in the studies analyzed, the complexity of MSC metabolism and related therapeutic effects do not allow withdrawing definitive conclusions about the superiority of one tissue source over another, as well as about the best cell dose and the long-term durability of the effects of these procedures.
Journal ArticleDOI
Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up
Federico Giuseppe Usuelli,Miriam Grassi,Camilla Maccario,Marco Viganò,L Lanfranchi,Umberto Alfieri Montrasio,Laura de Girolamo +6 more
TL;DR: Both PRP and SVF were safe, effective treatments for recalcitrant Achilles tendinopathy, and the patients treated with SVF obtained faster results, thus suggesting that such a treatment should be taken into consideration for those patients who require an earlier return to daily activities or sport.